Guiding Principles for Developing Dietary Reference Intakes Based on Chronic Disease (2017)
Chapter: Appendix A: Open Session Agendas
Appendix A
Open Session Agendas
The committee held two open sessions in Washington, DC, on October 13, 2016, and January 9, 2017. The open session agendas for the public meeting and a workshop are presented below:
The Development of Guiding Principles for the Inclusion of Chronic Disease Endpoints in Future Dietary Reference Intakes Open Session
Committee on the Development of Guiding Principles for the Inclusion of Chronic Disease Endpoints in Future Dietary Reference Intakes
October 13, 2016
Keck Center of the National Academies
500 Fifth Street, NW, Washington, DC
Room 208
| 1:00 PM | Welcome Remarks, Shiriki Kumanyika, Ph.D., M.P.H., M.S.W., Committee Chair |
| 1:05 PM | Sponsor Perspectives on the Study Christopher Lynch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (NIH), U.S. Department of Health and Human Services (HHS) Christine Taylor, Office of Dietary Supplements, NIH, HHS Amanda McFarlane, Nutrition Research Division, Health Canada |
| 1:45 PM | Questions from the Committee |
| 2:30 PM | Informal Q&A on the Dietary Reference Intake (DRI) Experience Christine Taylor, Office of Dietary Supplements, NIH, HHS Linda Meyers, Office of Dietary Supplements, NIH, HHS |
| 3:00 PM | Public Comments |
| 3:05 PM | BREAK |
The Development of Guiding Principles for the Inclusion of Chronic Disease Endpoints in Future Dietary Reference Intakes A Public Workshop
Committee on the Development of Guiding Principles for the Inclusion of Chronic Disease Endpoints in Future Dietary Reference Intakes
January 9, 2017
National Academy of Sciences Building
2101 Constitution Avenue, NW Washington, DC
Lecture Room
| 8:30 AM | Welcome Remarks, Shiriki Kumanyika, Ph.D., M.P.H., M.S.W., Committee Chair |
SESSION I: CURRENT TOOLS FOR ASSOCIATING NUTRIENTS AND CHRONIC DISEASE
| 8:35 AM | Overview of the State of Biomarkers Marian Neuhouser, Ph.D., R.D., Fred Hutchinson Cancer Research Center |
| 8:55 AM | Using All the Data: Bayesian Models and the Determination of Optimal Blood Folate Concentration for Neural Tube Defect Prevention Krista Crider, Ph.D., U.S. Centers for Disease Control and Prevention |
| 9:15 AM | A Brief Overview of Absolute Risk Models and How They Can Be Used to Design Intervention Studies Ruth Pfeiffer, Ph.D., National Cancer Institute |
| 9:45 AM | Case Study: Diet and Alzheimer’s Disease Martha Clare Morris, Sc.D., Rush University |
| 10:05 AM | Panel Discussion Facilitator: Patrick J. Stover, Ph.D., Cornell University |
| 10:30 AM | BREAK |
SESSION II: EMERGING METHODOLOGIES FOR ESTABLISHING NUTRIENT-CHRONIC DISEASE RELATIONSHIPS
| 10:45 AM | Overview and Comparisons of Risk of Bias and Strength of Evidence Assessment Tools: Opportunities and Challenges in Applying DRIs Mei Chung, Ph.D., M.P.H., Tufts University |
| 11:05 AM | A Probabilistic Hazard Characterization Framework for Addressing Uncertainty and Variability Weihsueh Chiu, Ph.D., Texas A&M University |
| 11:25 AM | Pattern of Lipid Biomarkers to Predict Disease Risk Robert Clarke, Nuffield Department of Public Health |
| 11:45 AM | Uses of Agent-Based Modeling to Inform Policy and Science in Chronic Disease-Brief Overview Ross Hammond, Ph.D., Brookings Institution |
| 12:05 PM | Panel Discussion Facilitator: Susan Barr, Ph.D., R.D., University of British Columbia |
| 12:30 PM | BREAK |
SESSION III: USES OF DRIs
| 1:30 PM | Uses of DRIs and How to Incorporate DRIs with Chronic Disease Endpoints into Those Uses
|
| 2:45 PM | Panel Discussion Facilitator: Linda D. Meyers, M.S., Ph.D., Office of Dietary Supplements, NIH, HHS |
| 3:15 PM | Public Comments |
| 3:30 PM | Adjourn |
